rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Patrick J. McEnany

Director and Other role

Company insider

Files Form 4 as: President and CEO, Catalyst Pharmaceutical; Director, Cesca Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
257
Buys
38
Sells
18
Bought
$1.2M
Sold
$52.7M
Companies
2
Companies where not an officer
1
First trade
10 Jul 2006
Last trade
15 Jul 2026
Last filed
17 Jul 2026

Companies traded

Where they are an officer
Catalyst PharmaceuticalDirector, Officer, 10% owner, Other · Biotechnology · last 15 Jul 202636 buys · 18 sells
Everywhere else they filed: board seats, 10% stakes, other companies
Cesca TherapeuticsDirector · last 1 Jul 20142 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
60Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Jul 2026filed 17 Jul 2026Catalyst PharmaceuticalBiotechnologySEC FORM 4 Code D$131.4M4,171,559 at $31.50filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—3,552 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—10,540 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—740,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—400,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—740,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—400,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—270,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—272,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—73,810 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—43,591 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—34,921 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—3,534 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—3,552 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—10,540 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—270,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—272,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—73,810 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—43,591 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—34,921 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed56

Buys in green, sells in red, by the company’s sector.

Related people

Donald A. DenkhausDirector · Director at Catalyst Pharmaceuticals, filing Form 4 there in the last year
David S. TierneyDirector · Director at Catalyst Pharmaceuticals, filing Form 4 there in the last year
Steve MillerChief Op. & Scientific Officer · Chief Op. & Scientific Officer at Catalyst Pharmaceuticals, filing Form 4 there in the last year
Richard J. DalyPresident and CEO · President and CEO at Catalyst Pharmaceuticals, filing Form 4 there in the last year
William T. AndrewsChief Medical Officer · Chief Medical Officer at Catalyst Pharmaceuticals, filing Form 4 there in the last year